按改良Rankin量表评分和干预时机分层的因卒中行颈动脉内膜切除术后院内结局
该研究基于血管质量倡议(VQI)2012至2020年因卒中行颈动脉内膜切除术(CEA)的15601例患者,按术前改良Rankin量表(mRS)评分和卒中后至CEA时间分层,分析院内卒中/死亡。结果显示mRS评分降低和CEA时间增加与较低的围手术期卒中/死亡率相关(P趋势<.01)。
要点
- mRS 0-1组在≤2天行CEA的卒中/死亡发生率高于3-14天(3.6% vs 2.0%;OR 1.8;95%CI 1.2-2.7)。
- mRS 2组在15-90天行CEA的卒中/死亡发生率低于3-14天(2.1% vs 3.9%;OR 0.5;95%CI 0.3-0.96)。
- mRS 3-4组在≤2天行CEA的卒中/死亡发生率高于3-14天(8.0% vs 3.8%;OR 2.4;95%CI 1.5-3.9)。
核心结论
- 卒中后轻度残疾(mRS 0-1)患者似乎从3-14天内行CEA获益。
- 重度残疾(mRS 5)患者在任何时间点行CEA风险均很高,因结局差。
- 与现行指南相反,轻度残疾(mRS 2)患者可能从延迟至15-90天行CEA获益,中度残疾(mRS 3-4)患者可能从3-90天内行CEA获益,因院内结局可接受。
研究设计与样本
- 回顾性队列研究,纳入血管质量倡议(VQI)数据库中2012至2020年因既往卒中行CEA的所有患者。
- 共纳入15601例患者,按术前mRS评分(0-5)和卒中后至CEA时间(≤2天、3-14天、15-90天、91-180天)分层。
- 进一步分析将患者分为mRS 0-1、2、3-4和5队列。
- 主要结局为院内卒中/死亡。
主要发现
- mRS评分分布:0分30%,1分34%,2分17%,3分11%,4分8%,5分1%。
- CEA时机分布:≤2天9.3%,3-14天46%,15-90天36%,91-180天8.4%。
- mRS评分降低和CEA时间增加与较低的围手术期卒中/死亡率相关(P趋势<.01)。
- 以3-14天CEA为参照,mRS 0-1组≤2天CEA的卒中/死亡发生率更高(3.6% vs 2.0%;OR 1.8;95%CI 1.2-2.7)。
- mRS 2组≤2天CEA的卒中/死亡发生率相似(4.4% vs 3.9%;OR 1.2;95%CI 0.6-2.3),但15-90天CEA的发生率更低(2.1% vs 3.9%;OR 0.5;95%CI 0.3-0.96)。
临床怎么用
- 作者认为,卒中后mRS 0-1患者似乎从3-14天内行CEA获益。
- 作者认为,mRS 5患者在任何时间点行CEA风险均很高。
- 作者认为,与现行指南相反,mRS 2患者可能从延迟至15-90天行CEA获益,mRS 3-4患者可能从3-90天内行CEA获益。
- 作者建议,这些数据应结合索引事件后数周的临床情况考虑,以确定延迟CEA的净获益。
局限性
- mRS 5组样本量小,限制了有意义的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although the benefits of carotid endarterectomy (CEA) for treating symptomatic carotid stenosis are well known, the optimal timing of intervention after acute stroke and whether the optimal timing will vary with preoperative stroke severity has remained unclear. Therefore, we assessed the effect of stroke severity and timing of the intervention on the postoperative outcomes for patients who had undergone CEA for stroke. METHODS: We identified all patients in the Vascular Quality Initiative who had undergone CEA from 2012 to 2020 for prior stroke. The patients were stratified using the preoperative modified Rankin scale score (mRS score, 0-5) and time to CEA after stroke onset (≤2 days, 3-14 days, 15-90 days, 91-180 days). After univariate comparisons, the patients were stratified into the following mRS cohorts for further analysis: 0 to 1, 2, 3 to 4, and 5. The primary outcome was in-hospital stroke/death. RESULTS: We identified 15,601 patients, of whom 30% had had an mRS score of 0, 34% an mRS score of 1, 17% an mRS score of 2, 11% an mRS score of 3, 8% an mRS score of 4, and 1% an mRS score of 5. Overall, 9.3% of the patients had undergone CEA within ≤2 days, 46% within 3 to 14 days, 36% in 15 to 90 days, and 8.4% within 90 to 180 days. A decreasing mRS score and an increasing time to CEA were associated with lower rates of perioperative stroke/death (Ptrend < .01). After risk adjustment, with CEA at 3 to 14 days as the comparator group, the mRS score 0 to 1 group had had a higher incidence of stroke/death after CEA within ≤2 days (3.6% vs 2.0%; odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2-2.7). The mRS score 2 group had had a similar incidence of stroke/death after CEA within ≤2 days (4.4% vs 3.9%; OR, 1.2; 95% CI, 0.6-2.3) but a lower incidence after CEA at 15 to 90 days (2.1% vs 3.9%; OR 0.5; 95% CI, 0.3-0.96). The mRS score 3 to 4 group had had a higher incidence of stroke/death after CEA within ≤2 days (8.0% vs 3.8%; OR, 2.4; 95% CI, 1.5-3.9) but a similar incidence of stroke/death after CEA at 15 to 90 days (3.0% vs 3.8%; OR, 0.8; 95% CI, 0.5-1.3). For the mRS score 5 group, the stroke/death rates were ≥6.5% across all the time to CEA groups. However, the low sample size limited meaningful comparisons. CONCLUSIONS: Patients with minimal disability after stroke (mRS score, 0-1) seemed to benefit from CEA within 3 to 14 days. However, those with severe disability (mRS score 5) have a very high risk from CEA at any time point given the poor outcomes. In contrast to the current guidelines, patients with mild disability (mRS score 2) could benefit from delaying CEA to 15 to 90 days, and those with moderate disability (mRS score 3-4) might benefit from CEA within 3 to 90 days given the acceptable in-hospital outcomes. These data should be considered within the context of the clinical situation in the weeks after index event to determine the net benefit of delayed CEA.
引用
- Solomon Y, Marcaccio CL, Rastogi V, et al. In-hospital outcomes after carotid endarterectomy for stroke stratified by modified Rankin scale score and time of intervention. J Vasc Surg. 2022. PMID: 36395901. doi:10.1016/j.jvs.2022.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。